Womens Health Diagnostics Market Research, 2030
The global womens health diagnostics market size was valued at $19.2 billion in 2020, and is projected to reach $36.3 billion by 2030, growing at a CAGR of 6.9% from 2021 to 2030.
Women's health is the branch of medicine that mainly focuses on the treatment and diagnosis of diseases and conditions that affect a woman's health. Women's health diagnostic method includes screening, testing or diagnosing, and monitoring of several women-related disorders, such as breast cancer, ovarian cancer, cervical cancer, menopause, and pregnancy. Different types of test are available for the diagnosis women health-related diseases. The medical diagnostics devices, such as biopsy device, imaging & monitoring system, mammography system, and other detect cancer, remove blockages, and capture the images of internal organs help for screening & diagnosis of disease. The diagnostic test includes breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy & ovulation testing & ovarian cancer testing. The use of tests for screening and detection of various disorders is necessary to prevent complications and improve quality of life. Health tests are vital for improving health and preventing and treating serious diseases.
The womens health diagnostics market is segmented into Type and End User. Increase in geriatric female population globally, increase in incidence of chronic and lifestyle disorders, and rise in demand for the point of care diagnostic testing are key factors that lead the womens health diagnostics market growth. Moreover, support of government initiatives to promote women health awareness across the globe also drives the women’s health diagnostics market growth. Rise in novel application of imaging techniques has led to the increase in implementation of imaging techniques for diagnosis. Moreover, increase in demand for advanced technologies and availability of diagnostic centers accelerate the market growth. Increase in prevalence of various health-related disorders among women, such as breast cancer and infertility, growth in awareness about women’s health-related tests, high demand for point-of-care diagnostic testing, and development of numerous diagnostic & imaging centers drive the growth of the women’s health diagnostics market. In addition, surge in healthcare expenditure, growth in awareness about malignant tumors, and availability of newer and advanced diagnostic systems are expected to further boost the market growth in near future.. Moreover, rise in number of developments and strategic partnerships among the diagnostic device key players and their entry in developing economies provide numerous opportunities for market expansion. However, expensive imaging procedures and lack of skilled professionals restrain the market growth. Conversely, huge untapped market potential in the emerging countries, such as South Africa and India, and development of novel and advanced imaging procedures such as miniature devices are expected to provide lucrative opportunities to the market players.
The womens health diagnostics industry is segmented on the basis of type, end user, and region. On the basis of type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The devices segment is further segmented into biopsy devices and imaging and monitoring system. Imaging and monitoring systems segment is further segmented into ultrasound device, mammography systems & other. Ultrasound imaging systems is further sub segmented into OB/GYN ultrasound and breast ultrasound. Mammography systems are further categorized as analog mammography systems, digital mammography systems, and breast tomosynthesis system. The diagnostic tests segment is further categorized as breast cancer testing, cervical cancer testing, prenatal genetic screening and carrier testing, pregnancy and ovulation testing, and ovarian cancer testing. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening & carrier testing include, tests for cystic fibrosis and other diseases. The pregnancy & ovulation testing segment is further bifurcated into lab-based pregnancy & ovulation testing, and home-based pregnancy & ovulation testing. Depending on end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Type Segment Review
Based on type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The diagnostic devices segment is further sub-segmented into biopsy devices and imaging and monitoring system. Imaging and monitoring systems is further sub-segmented into ultrasound device, mammography systems & other.
The diagnostic tests segment is further categorized as breast cancer testing, cervical cancer testing, prenatal genetic screening and carrier testing, pregnancy and ovulation testing, and ovarian cancer testing. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. The diagnostic tests segment was the highest contributor to the market in 2020. Increase in prevalence of various health-related disorders among women, such as cancer and infertility, growth in awareness about women’s health-related tests, high demand for point-of-care diagnostic testing, and development of numerous diagnostic & imaging centers drive the women’s health diagnostics market for tests.
By End User Segment Review
By end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. The hospitals and clinics segment was the highest contributor to the market in 2020. The increase in incidence of breast and ovarian cancer has led to a significant rise in the number of hospitalization.
Region Segment Review
By region, North America constituted the highest womens health diagnostics market share in 2020, owing to numerous technological developments related to diagnosis of women and imaging techniques in this region. Asia-Pacific is projected to grow at the highest CAGR during the womens health diagnostics market forecast, owing to entry of market players with novel tests and kits in the market, and rise in awareness about women’s health diagnostics technology.
This report provides comprehensive competitive analysis and profiles of prominent market players ABBOTT, BD, Cardinal Health, Inc., F.Hoffmann-La Roche Ltd., General Electric Company, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Medical Solutions USA, Inc., and bioMérieux SA.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the womens health diagnostics industry, market segments, current trends, estimations, and dynamics of the womens health diagnostics market analysis from 2020 to 2030 to identify the prevailing womens health diagnostics market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the womens health diagnostics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global womens health diagnostics market trends, key players, market segments, application areas, and market growth strategies.
Womens Health Diagnostics Market Report Highlights
By End User
Key Market Players
KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE), GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY), BECTON, DICKINSON AND COMPANY, F. HOFFMANN-LA ROCHE LTD., ABBOTT LABORATORIES, QUEST DIAGNOSTICS INCORPORATED., CARDINAL HEALTH, INC., bioMérieux SA, SIEMENS AKTIENGESELLSCHAFT, HOLOGIC, INC.
Adoption of women’s health diagnostics is expected to increase due to escalation of various types of health issues in women, such as breast cancer, ovarian cancer cervical cancer, and other. These diagnostics procedures are used for detecting, screening, and monitoring of disease and affected tissues. Upsurge in cases of women-related health issues and increase in prevalence of cancer make it imperative to use various diagnosing techniques and tests for the detection of disease. Moreover, increase in R&D activities to develop novel techniques and tests with higher accuracy, rise in geriatric women population, and surge in affordability in developing economies are projected to supplement the market growth. However, high cost of imaging systems and dearth of skilled professionals are expected to impede the market growth.
The use of women’s diagnostics procedures is highest in North America, owing to increase in awareness about women-related disorders and heavy expenditure by the government on healthcare, followed by Asia-Pacific and Europe. In addition, diagnostics and tests related providers and distributors focus on expanding their presence in the emerging economies, which is anticipated to drive the market growth.